Wave Life Sciences (WVE) Change in Cash (2014 - 2026)

Wave Life Sciences (WVE) has 13 years of Change in Cash data on file, last reported at -$176.6 million in Q2 2026.

• Quarterly Change in Cash fell 410.62% year-over-year to -$176.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $159.6 million (up 192.36% YoY) and the FY2025 annual result came in at $300.0 million, up 194.77% from the prior year.
• Change in Cash eased to -$176.6 million in Q2 2026, from -$57.5 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $405.9 million in Q4 2025 to a low of -$176.6 million in Q2 2026.
• A 5-year average of $12.1 million and a median of -$22.8 million in 2022 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2025 — Change in Cash soared 4682.88% — and 2026, when it tumbled 410.62%.
• Tracing WVE's Change in Cash over 5 years: stood at -$8.5 million in 2022, then soared by 815.0% to $60.4 million in 2023, then sank by 114.66% to -$8.9 million in 2024, then soared by 4682.88% to $405.9 million in 2025, then slumped by 143.51% to -$176.6 million in 2026.
• The last three Change in Cash figures came in at -$176.6 million (Q2 2026), -$57.5 million (Q1 2026), and $405.9 million (Q4 2025), per Business Quant data.